People with high lifetime exposure to psychosocial stress had an impaired ability to produce the dopamine necessary for coping with a stressful situation, according to an imaging study published online in eLife.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
An international genome-wide association study of 200,000 people has established that the risk of post-traumatic stress disorder (PTSD) is heritable, silencing theories that the disorder is solely a social construct.
SAN DIEGO—Signs point to possible approval of MDMA-assisted psychotherapy for post-traumatic stress disorder by late 2021, with Rick Doblin, PhD, telling Psych Congress attendees that this could mark the start of a new field of therapy.
A drug that increases levels of a key endocannabinoid in the brain may be useful for helping patients with post-traumatic stress disorder (PTSD) unlearn fear, suggests an early-stage study published online in Biological Psychiatry.
Refugees and asylum seekers fleeing conflict in their homeland often have high levels of psychological distress and should undergo routine mental health screening at arrival to a new country, researchers said at the North American Refugee Health…